Advances in the treatment of secondary and tertiary hyperparathyroidism

Secondary hyperparathyroidism (SHPT) and tertiary hyperparathyroidism (THPT) are common and complicated clinical endocrine diseases. The parathyroid glands maintain endocrine homeostasis by secreting parathyroid hormone to regulate blood calcium levels. However, structural alterations to multiple or...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li-Xi, Zhang, Ben, Liu, Xu-Yao, Wang, Zi-Ming, Qi, Peng, Zhang, Tong-Yue, Zhang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763452/
https://www.ncbi.nlm.nih.gov/pubmed/36561571
http://dx.doi.org/10.3389/fendo.2022.1059828
_version_ 1784853063461240832
author Zhang, Li-Xi
Zhang, Ben
Liu, Xu-Yao
Wang, Zi-Ming
Qi, Peng
Zhang, Tong-Yue
Zhang, Qiang
author_facet Zhang, Li-Xi
Zhang, Ben
Liu, Xu-Yao
Wang, Zi-Ming
Qi, Peng
Zhang, Tong-Yue
Zhang, Qiang
author_sort Zhang, Li-Xi
collection PubMed
description Secondary hyperparathyroidism (SHPT) and tertiary hyperparathyroidism (THPT) are common and complicated clinical endocrine diseases. The parathyroid glands maintain endocrine homeostasis by secreting parathyroid hormone to regulate blood calcium levels. However, structural alterations to multiple organs and systems occur throughout the body due to hyperactivity disorder in SHPT and THPT. This not only decreases the patients’ quality of life, but also affects mortality. Since current treatments for these diseases remains unclear, we aimed to develop a comprehensive review of advances in the treatment of SHPT and THPT according to the latest relevant researches.
format Online
Article
Text
id pubmed-9763452
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97634522022-12-21 Advances in the treatment of secondary and tertiary hyperparathyroidism Zhang, Li-Xi Zhang, Ben Liu, Xu-Yao Wang, Zi-Ming Qi, Peng Zhang, Tong-Yue Zhang, Qiang Front Endocrinol (Lausanne) Endocrinology Secondary hyperparathyroidism (SHPT) and tertiary hyperparathyroidism (THPT) are common and complicated clinical endocrine diseases. The parathyroid glands maintain endocrine homeostasis by secreting parathyroid hormone to regulate blood calcium levels. However, structural alterations to multiple organs and systems occur throughout the body due to hyperactivity disorder in SHPT and THPT. This not only decreases the patients’ quality of life, but also affects mortality. Since current treatments for these diseases remains unclear, we aimed to develop a comprehensive review of advances in the treatment of SHPT and THPT according to the latest relevant researches. Frontiers Media S.A. 2022-12-06 /pmc/articles/PMC9763452/ /pubmed/36561571 http://dx.doi.org/10.3389/fendo.2022.1059828 Text en Copyright © 2022 Zhang, Zhang, Liu, Wang, Qi, Zhang and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Zhang, Li-Xi
Zhang, Ben
Liu, Xu-Yao
Wang, Zi-Ming
Qi, Peng
Zhang, Tong-Yue
Zhang, Qiang
Advances in the treatment of secondary and tertiary hyperparathyroidism
title Advances in the treatment of secondary and tertiary hyperparathyroidism
title_full Advances in the treatment of secondary and tertiary hyperparathyroidism
title_fullStr Advances in the treatment of secondary and tertiary hyperparathyroidism
title_full_unstemmed Advances in the treatment of secondary and tertiary hyperparathyroidism
title_short Advances in the treatment of secondary and tertiary hyperparathyroidism
title_sort advances in the treatment of secondary and tertiary hyperparathyroidism
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763452/
https://www.ncbi.nlm.nih.gov/pubmed/36561571
http://dx.doi.org/10.3389/fendo.2022.1059828
work_keys_str_mv AT zhanglixi advancesinthetreatmentofsecondaryandtertiaryhyperparathyroidism
AT zhangben advancesinthetreatmentofsecondaryandtertiaryhyperparathyroidism
AT liuxuyao advancesinthetreatmentofsecondaryandtertiaryhyperparathyroidism
AT wangziming advancesinthetreatmentofsecondaryandtertiaryhyperparathyroidism
AT qipeng advancesinthetreatmentofsecondaryandtertiaryhyperparathyroidism
AT zhangtongyue advancesinthetreatmentofsecondaryandtertiaryhyperparathyroidism
AT zhangqiang advancesinthetreatmentofsecondaryandtertiaryhyperparathyroidism

Ejemplares similares